Investments
R42-AlgoDynamix: Markets or Mania (May edition)
Join financial innovation leaders Dr. Jeremy Sosabowski (AlgoDynamix CEO), Prof. Ronjon Nag (R42 Founder), and Prof. Frank Sortino (Sortino ratio creator) as they decode whether we're witnessing rational markets or investment mania. Gain valuable insights on risk management strategies t...
The need-to-know about doing business in China, best practices and practical advice
Recognising the critical need for Western businesses to navigate the complexities of China’s evolving intellectual property (IP) landscape, Ting Zhang FRSA, Founder and CEO of Crayfish.io, is partnering with the IPI Academy to deliver an essential training course: “Best Practices for Do...
CMR Surgical raises more than $200m to accelerate growth in US and globally
Global surgical robotics company CMR Surgical in Cambridge has closed a funding round of more than $200 million to underpin worldwide expansion – notably in the US.The haul has been raised through a combination of equity and debt capital to support the company’s ambitious growth plans.T...
Cambridge Innovation Capital co-leads $31M seed financing for TRIMTECH Therapeutics to advance neurodegenerative disease treatments
Cambridge Innovation Capital (CIC), a leading investor in life sciences and deep tech companies, today announces its role as a co-lead investor in TRIMTECH Therapeutics’ $31 million (£25 million) seed funding round. The financing round, which was oversubscribed, was also co-led by SV He...
British Patient Capital announces £20m commitment to Cambridge Innovation Capital £100m Opportunity Fund
British Patient Capital, a commercial subsidiary of the British Business Bank, has made a £20 million cornerstone commitment to Cambridge Innovation Capital’s (CIC) £100 million Opportunity Fund, alongside Aviva Investors.CIC was launched in 2013 and invests in deep tech and life scienc...
New £100m Cambridge Innovation Capital fund launched
Cambridge Innovation Capital has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British Patient Capital – to invest in growing DeepTech and life science companies.The aim is to help our best businesses clinch growth capital in the UK rather than being for...
Epitopea announces license and research collaboration agreement with MSD to identify cryptigenTM tumor-specific antigens
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to identify CryptigenTM tumor-specif...
Cambridge GaN Devices secures $32M to drive growth in power semiconductor industry
Cambridge GaN Devices (CGD), a leading innovator in gallium nitride (GaN) power devices, has successfully closed a $32 million Series C funding round. The investment was led by a strategic investor with participation from British Patient Capital and supported by existing investors Parkw...
Salience Labs closed Series A round led by Applied Ventures and ICM HPQC Fund
Salience Labs Limited, a leader in photonic solutions targeting connectivity for AI datacenter infrastructure, today announced the successful close of $30 million in Series A financing led by ICM HPQC Fund and Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc., to...
R42-AlgoDynamix: Markets or Mania (special edition event!)
Join financial innovation leaders Dr. Jeremy Sosabowski (AlgoDynamix CEO), Prof. Ronjon Nag (R42 Founder), and Prof. Frank Sortino (Sortino ratio creator) as they decode whether we're witnessing rational markets or investment mania. Gain valuable insights on risk management strategies t...